Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Imatinib Mesylate in Treating Patients With Salivary Gland Cancer

ClinicalTrials.gov ID: NCT00045669

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00045669. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 4:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study Of Imatinib Mesylate In Adenoid Cystic, Lymphoepithelioma-Like And Myoepithelial Salivary Gland Carcinomas

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: Phase II trial to study the effectiveness of imatinib mesylate in treating patients who have unresectable and/or metastatic salivary gland cancer.

Study identification

NCT ID
NCT00045669
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
16 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2002 (Type not available)
Primary completion
Jan 2004 (Actual)
Completion
Jan 2005 (Actual)
Last update posted
Feb 15, 2019

2002 – 2005

United States locations

U.S. sites
14
U.S. states
5
U.S. cities
13
Facility City State ZIP Site status
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
Louis A. Weiss Memorial Hospital Chicago Illinois 60640 —
Decatur Memorial Hospital Cancer Care Institute Decatur Illinois 62526 —
Evanston Northwestern Health Care - Evanston Hospital Evanston Illinois 60201 —
Ingalls Memorial Hospital Harvey Illinois 60426 —
LaGrange Memorial Hospital LaGrange Illinois 60525 —
Loyola University Medical Center Maywood Illinois 60153 —
Oncology/Hematology Associates of Central Illinois, P.C. Peoria Illinois 61602 —
Central Illinois Hematology Oncology Center Springfield Illinois 62701 —
Fort Wayne Medical Oncology and Hematology, Incorporated Fort Wayne Indiana 46885-5099 —
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601 —
Lakeland Medical Center - St. Joseph Saint Joseph Michigan 49085 —
Siteman Cancer Center St Louis Missouri 63110 —
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792-6164 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00045669, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 15, 2019 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.